Van Maldergem syndrome 1 is a rare genetic condition that affects development of the face, bones, brain, and other organs. People with Van Maldergem syndrome 1 often have distinctive facial features, joint laxity, differences in the hands or feet, and developmental delay or intellectual disability. Hearing loss and feeding or breathing difficulties can occur in infancy, and seizures are possible in some. It is lifelong, and care focuses on supportive therapies, hearing support, seizure control, and surgery for structural differences when needed. The outlook varies, but many living with Van Maldergem syndrome 1 do well with coordinated care from pediatrics, neurology, genetics, therapy, and surgical teams.
Overview
Van maldergem syndrome 1Symptoms
Van Maldergem syndrome 1 features are usually noticed at birth or in early childhood. Many have distinctive facial differences, ear changes with hearing loss, limb or joint anomalies, and feeding or breathing issues, along with developmental delay and learning difficulties.
Outlook and prognosis
Many living with Van Maldergem syndrome 1 grow and learn at their own pace and often need lifelong, team-based support for movement, feeding, speech, and learning. Health concerns vary widely, from mild to complex. Early therapies and regular monitoring can meaningfully improve daily function.
Causes and risk factors
Van Maldergem syndrome 1 results from changes in the DCHS1 gene and is inherited in an autosomal recessive pattern. Risk increases when both parents are carriers, in consanguineous families, or with an affected sibling. Environment and lifestyle don’t cause it.
Genetic influences
Genetics is central in Van Maldergem syndrome 1, which stems from inherited changes in DCHS1. Most cases follow autosomal recessive inheritance, so both parents are typically carriers. Genetic testing confirms the diagnosis and enables carrier and prenatal options.
Diagnosis
Doctors suspect Van Maldergem syndrome 1 from distinctive facial features, limb differences, developmental delays, and hearing issues. Genetic diagnosis of Van Maldergem syndrome 1 is confirmed with genetic testing, supported by targeted exams and imaging.
Treatment and drugs
Treatment for Van Maldergem syndrome 1 is personalized and usually coordinated by a multidisciplinary team. Care may include early therapies (physical, occupational, speech), hearing and vision support, orthodontic or surgical management of craniofacial differences, and learning supports at school. Regular follow-up helps adjust plans as needs change.
Symptoms
Day to day, families often first notice differences in feeding, muscle tone, or the way the face and ears look. Parents may spot early features of Van maldergem syndrome 1 in infancy or early childhood, alongside delays in sitting, walking, or talking. Features vary from person to person and can change over time. Doctors may also find differences in bones, joints, hearing, and the brain on exam or imaging.
Families may notice a broad nose, wide-set eyes, or a small chin. These traits are part of the syndrome and do not harm health by themselves. They can help doctors recognize the condition.
Ears may look cupped or sit a bit lower, and some children have narrow ear canals. In Van maldergem syndrome 1, mild to moderate hearing loss can occur, which can affect speech learning. Regular hearing checks help guide early support.
In infancy there may be a weak suck or trouble coordinating suck, swallow, and breathe. This can lead to slow weight gain or reflux. A feeding plan with a specialist often makes mealtimes easier.
Babies and children may feel “floppy” and seem to tire easily during movement. Clinicians call this hypotonia, which means the muscles don’t keep a firm resting tension. It often improves with time and therapy.
How people usually first notice Van maldergem syndrome 1?
Families often notice the first signs of Van Maldergem syndrome 1 shortly after birth, when a baby has distinctive facial features, unusually soft or low muscle tone, and feeding or breathing difficulties. Doctors may first suspect it in the newborn period or early infancy because of joint laxity, limb or ear shape differences, and later-onset developmental delays, which become clearer as the child begins to miss early milestones like rolling or sitting. In many cases, “how Van Maldergem syndrome 1 is first noticed” is through a combination of these visible traits and early developmental concerns, prompting genetic testing to confirm the diagnosis.
Types of Van maldergem syndrome 1
Van Maldergem syndrome 1 is a rare genetic condition with a few recognized clinical variants that can shape how symptoms show up and how severe they are. People with Van Maldergem syndrome often share core features, but the balance of learning differences, facial and ear differences, joint laxity, and bone changes can differ by variant. Clinicians often describe them in these categories: variants linked to one gene (DCHS1) and those linked to a closely related gene (FAT4), which influence early development in slightly different ways.
DCHS1-related variant
Features often include distinctive facial shape, joint laxity, broad thumbs or toes, and differences in the outer ear. Hearing differences and developmental delays are common, with some children walking and talking later than peers. Heart or kidney differences are less frequent but can occur.
FAT4-related variant
Many features overlap with the DCHS1 form, but bone and limb differences may be more pronounced in some people. Some may also show broader involvement of the lymph system or additional skeletal findings. Early symptoms of Van Maldergem syndrome can include feeding difficulties and low muscle tone in infancy.
Hennekam–Van Maldergem spectrum
Some families show features that bridge Van Maldergem syndrome and Hennekam lymphatic malformation syndrome due to changes in the same pathway. In practice, this means similar facial features with variable lymphatic swelling, intestinal protein loss, or limb differences. Not everyone will experience every type.
What genetics can tell you about symptoms
Some people with Van Maldergem syndrome 1 have mutations in the DCHS1 gene, which can disrupt brain and facial development, leading to intellectual disability, distinctive facial features, and joint laxity. Changes in this gene can also affect ear structure and bone growth, causing hearing loss and skeletal differences.
Causes and risk factors
Van Maldergem syndrome 1 is caused by harmful changes in the DCHS1 gene that affect early development. Most children inherit one nonworking copy from each parent in an autosomal recessive pattern, and rarely the gene change is new. Key risk factors for Van Maldergem syndrome 1 include having two carrier parents and parents who are related. Some risks are written in our DNA, passed down through families. Lifestyle or environment does not change the chance of inheriting it, but early diagnosis, nutrition, and therapies can shape health and function.
Environmental and biological risk factors
For a rare condition like Van maldergem syndrome 1, families often want to know what might raise the chance of it occurring. Doctors often group risks into internal (biological) and external (environmental). When people ask about environmental risk factors for Van maldergem syndrome 1, the short answer is that none are clearly proven at this time. Current evidence points to changes that arise very early in development, before birth.
Research has not identified specific toxins, infections, medications, or pollutants that raise the chance of Van maldergem syndrome 1. Available reports have not shown a consistent environmental pattern.
The biological events that lead to this condition occur during the first weeks of embryo formation. This means any underlying risk is established long before birth.
Delivery type, birth timing, or labor complications have not been shown to increase the likelihood of Van maldergem syndrome 1. Features seen at birth reflect earlier development rather than delivery events.
Unlike some chromosome conditions, advanced maternal or paternal age does not show a clear association. Most available cases do not follow an age-related pattern.
Genetic risk factors
The strongest genetic risk for Van Maldergem syndrome 1 is inheriting two non-working copies of the DCHS1 gene. These changes are passed in an autosomal recessive way, so healthy carrier parents can have an affected child. Some risk factors are inherited through our genes. Understanding the genetic risk factors for Van Maldergem syndrome 1 can guide family planning and testing choices.
DCHS1 gene changes: Harmful changes in the DCHS1 gene are the direct cause of Van Maldergem syndrome 1. Most affected people have two faulty copies—either the same change on both copies or two different changes.
Autosomal recessive pattern: The condition follows an autosomal recessive pattern. A child is affected only if they receive one non-working DCHS1 copy from each parent. This explains why parents are usually healthy.
Carrier parents: Parents are often healthy carriers with one altered DCHS1 copy. When both are carriers, each pregnancy has a 25% (1 in 4) chance of Van Maldergem syndrome 1. Each child also has a 50% (1 in 2) chance to be a carrier.
Family history: Having an affected child or sibling signals that both parents likely carry a DCHS1 change. Future pregnancies in the same pairing carry the same 25% (1 in 4) chance to be affected. Extended relatives may be carriers without symptoms.
Consanguinity: Parents who are related by blood are more likely to share the same rare DCHS1 change. This increases the chance their child inherits two non-working copies. Carrier testing can help clarify this risk.
Affected parent risks: An adult with Van Maldergem syndrome 1 will pass one altered DCHS1 copy to every child. If their partner is a carrier, each child has a 50% (1 in 2) chance to be affected. If the partner is not a carrier, all children will be healthy carriers.
Related gene, FAT4: A similar condition, Van Maldergem syndrome 2, results from changes in FAT4 rather than DCHS1. Testing that pinpoints DCHS1 confirms type 1 and guides accurate family risk estimates.
Lifestyle risk factors
Van Maldergem syndrome 1 is a genetic condition; lifestyle habits do not cause it, but daily routines can shape symptoms, function, and complications over time. Practical choices in movement, feeding, sleep, and sensory support can ease challenges linked to hypotonia, joint laxity, craniofacial differences, and developmental delays. This overview explains how lifestyle affects Van maldergem syndrome 1 by highlighting specific behaviors that may help or hinder health and participation.
Regular, low‑impact movement and guided physiotherapy can build muscle tone and coordination in hypotonia. Better strength and balance may reduce falls and support motor milestones.
Avoiding hyperextension and choosing joint‑friendly activities lowers the risk of pain and dislocations from ligament laxity. Supportive footwear and bracing during daily tasks can improve stability.
Balanced protein and energy intake supports growth and muscle development when activity is limited. Preventing excess weight reduces strain on lax joints and makes mobility and breathing easier.
Upright posture, safe textures, and paced feeding can limit choking or aspiration in oromotor dysfunction. Efficient feeding improves calorie intake and energy for therapy and learning.
Risk prevention
Van Maldergem syndrome 1 is a genetic condition, so you can’t prevent it from occurring, but you can lower the risk of complications and protect long‑term health. Even if you can’t remove all risks, prevention can reduce their impact. Spotting issues early and building steady routines—hearing checks, vision care, sleep and breathing support, and therapies—often makes daily life easier. Genetic counseling can also help with family planning and understanding options for future pregnancies.
A genetics professional can explain inheritance, recurrence risk, and testing options for relatives. They can also discuss prenatal and preimplantation options for future pregnancies.
Coordinated care with pediatrics, genetics, ENT, eye, dental, therapy, and orthopedic teams helps catch problems before they snowball. A shared care plan reduces gaps between appointments and treatments.
Regular hearing tests can find conductive or mixed hearing loss early. Timely support like hearing aids and speech therapy helps communication and learning.
Routine eye exams can pick up vision issues that affect development and safety. Early glasses, patching, or other treatments support learning and movement.
Transmission
Van maldergem syndrome 1 is not contagious; you can’t catch it or pass it through contact, coughing, or food. It is present from birth and results from changes in a gene that affect early development.
The genetic transmission of Van maldergem syndrome 1 is autosomal recessive. When both parents are healthy carriers of a change in the same gene, each pregnancy has a 25% (1 in 4) chance of a child having the condition, a 50% (1 in 2) chance the child will be a carrier, and a 25% (1 in 4) chance the child will be unaffected and not a carrier. A genetics professional can explain how Van maldergem syndrome 1 is inherited in your family.
When to test your genes
Van Maldergem syndrome 1 is a genetic condition, so testing is most useful when there’s a strong family history, characteristic features in a child, or unexplained developmental differences. Genetic testing confirms the diagnosis, guides care plans, and informs recurrence risks for future pregnancies. Consider testing before pregnancy, during diagnostic workups, or when planning supports.
Diagnosis
Van maldergem syndrome 1 is typically identified by a mix of distinctive physical features and developmental patterns, then confirmed with targeted lab tests. You might notice small changes in daily routines—like delays in motor or speech milestones—that lead a clinician to look more closely. Some conditions have a genetic link, meaning they can run in families. Genetic diagnosis of Van maldergem syndrome 1 usually involves confirming a suspected clinical picture with DNA-based testing.
A genetics-informed exam looks for a pattern of facial, ear, limb, and growth features that tend to occur together. Recognizing these patterns helps distinguish Van maldergem syndrome 1 from similar conditions.
Standardized tools document motor, speech, learning, and daily-living skills over time. Tracking strengths and needs helps guide therapies while the diagnostic workup continues.
Screening can identify hearing or vision issues that sometimes accompany syndromic conditions. Early detection supports communication and learning while other tests are pending.
Your provider may suggest MRI to look closer. Imaging can reveal structural brain differences that, while not specific on their own, may support the suspected diagnosis and inform care.
Stages of Van maldergem syndrome 1
Van maldergem syndrome 1 does not have defined progression stages. It is present from birth and tends to remain relatively stable over time, though specific features and support needs can change as a child grows. Different tests may be suggested to help confirm the diagnosis, such as a physical exam, hearing and vision checks, imaging, and genetic testing. Clinicians usually review early symptoms of Van maldergem syndrome 1 alongside exam findings and family history, and ongoing monitoring often focuses on development, hearing, feeding, and orthopedic concerns.
Outlook and prognosis
Families often want to know how life will change after a diagnosis of Van Maldergem syndrome 1, and the answer depends on which features are most prominent for a given person. Everyone’s journey looks a little different. Some children have significant developmental delays and differences in facial bones or ears, while others have milder challenges and make steady progress with early therapies. Early care can make a real difference, especially for feeding, hearing, mobility, and communication skills.
Looking at the long-term picture can be helpful. Many people with Van Maldergem syndrome 1 live into adulthood, and life expectancy is often influenced more by specific complications than by the condition itself. Breathing or feeding difficulties in infancy, recurrent chest infections, severe hearing loss, or orthopedic issues can shape day-to-day health and may raise medical risks if not addressed. When thinking about the future, it helps to ask your clinicians about early symptoms of Van Maldergem syndrome 1 that signal a need for urgent care, such as pauses in breathing, dehydration from poor feeding, or rapidly worsening chest problems.
Prognosis refers to how a condition tends to change or stabilize over time. With coordinated support—developmental therapies, hearing support, careful monitoring of the airway and skeleton—many people maintain good overall health and continue to gain new skills, even if milestones arrive later than average. Mortality is not well defined due to the rarity of Van Maldergem syndrome 1, but published reports suggest that the main risks relate to severe airway or feeding complications in early life rather than a progressive decline. Talk with your doctor about what your personal outlook might look like, including which screenings and supports fit your situation now and in the years ahead.
Long-term effects
Van Maldergem syndrome 1 can involve differences in development, movement, hearing, and facial growth that tend to persist across childhood and adulthood. Early symptoms of Van Maldergem syndrome 1 may appear in infancy, but the long-term picture usually centers on learning, mobility, and sensory changes. Long-term effects vary widely, and some features are more prominent than others over time. Many families see a stable course, while select features can change slowly with growth and aging.
Many people have lifelong learning differences ranging from mild to more significant. Daily skills often improve over time, but support needs may remain.
Speech can be delayed and articulation may stay challenging. Expressive language often lags behind understanding in the long term.
Conductive hearing loss is common due to ear structure differences. Hearing levels may fluctuate in childhood and then stabilize in later years.
Strabismus or refractive errors can persist. Depth perception and eye coordination may remain areas of difficulty.
How is it to live with Van maldergem syndrome 1?
Living with Van Maldergem syndrome 1 often means coordinating many supports—regular visits with specialists, therapies for movement, speech, and learning, and practical adaptations at home and school to make daily tasks safer and easier. People with this condition may have differences in facial features, joints, hearing, or development that shape how they communicate, move, and learn, and progress can be slow but meaningful with consistent therapy. Families and caregivers become key partners, balancing medical appointments with everyday life and finding routines that reduce fatigue and maximize independence, while friends, teachers, and community members can help by offering patience, clear communication, and accessible environments. Many families describe a steady rhythm: challenges that require planning, matched by moments of growth, connection, and pride in each new skill.
Treatment and drugs
Treatment for Van Maldergem syndrome 1 focuses on managing symptoms and supporting development over time, since there’s no single cure. Care often involves a team approach with regular physical, occupational, and speech therapy to build motor skills, communication, and independence; hearing aids or glasses may be used if hearing or vision is affected. Doctors sometimes recommend a combination of lifestyle changes and drugs, such as antiseizure medications if seizures occur, sleep support if breathing is disrupted at night, and pain relief or muscle relaxants for stiffness as needed. Surgery may be considered to correct certain bone or joint differences, improve airway or ear structures, or address dental and jaw alignment, followed by rehabilitation to protect function. Supportive care can make a real difference in how you feel day to day, and ongoing follow-up with genetics, neurology, orthopedics, ENT, and cardiology helps tailor treatment as needs change.
Non-drug treatment
Feeding, movement, hearing, and learning can be affected in day-to-day life. People with Van maldergem syndrome 1 often benefit from a coordinated plan that starts early and adapts as needs change. Alongside medicines, non-drug therapies often lay the foundation for progress over time.
Team-based services in infancy and toddler years can boost developmental skills. Addressing early symptoms of Van maldergem syndrome 1—like delayed sitting or limited babbling—helps set helpful routines at home.
Guided exercises build strength, balance, and coordination. Therapists also work on safer transfers, posture, and joint protection.
Practice with dressing, play, and hand skills supports independence. Adaptive tools and hand splints can make daily tasks easier and protect joints.
Speech-language therapy supports communication, from first sounds to language and alternative communication systems. Feeding therapy can improve chewing and swallowing safety and reduce mealtime stress.
Your genes may have an impact on how drugs work for you
Medicines used for Van Maldergem syndrome 1 can work differently depending on each person’s genes, which influence how drugs are absorbed, broken down, and reach their targets. Pharmacogenetic testing may guide safer dosing and choices for pain control, seizures, or behavioral symptoms.
Pharmacological treatments
Medicines for Van maldergem syndrome 1 focus on easing day-to-day symptoms like seizures, reflux, sleep problems, drooling, constipation, or muscle tone issues. Early symptoms of Van maldergem syndrome 1, such as seizures or feeding reflux, often guide which drugs are tried first. Not everyone responds to the same medication in the same way. Treatment plans are individualized and adjusted over time to balance benefits and side effects.
Levetiracetam, valproate, or lamotrigine are common options to prevent seizures. Doctors select based on seizure type, age, and other health factors. Doses are adjusted slowly to find the lowest effective amount.
Omeprazole or lansoprazole can reduce stomach acid and ease reflux-related cough or discomfort. This may help feeding and sleep in infants and children.
Polyethylene glycol (PEG 3350) or lactulose can soften stools and reduce straining. Regular use is often needed, with dose changes based on bowel patterns.
Melatonin may improve sleep onset and schedule, especially when bedtime routines are not enough. In some cases, clonidine is used at low doses under close supervision.
Genetic influences
Genetics play a central role in Van Maldergem syndrome 1. It is usually caused by changes in a gene called DCHS1, which helps cells stick together and organize during early development. The condition typically appears when a child inherits two altered copies—one from each parent—while the parents usually feel healthy and carry one copy. A “carrier” means you hold the gene change but may not show symptoms. This pattern is called autosomal recessive inheritance: with each pregnancy there is a 25% (1 in 4) chance of a child with the condition, a 50% (1 in 2) chance of a carrier, and a 25% chance of neither. These gene changes are not caused by anything parents did during pregnancy or by lifestyle. Genetic testing for Van Maldergem syndrome 1 can confirm a DCHS1 change and can also check a related gene, FAT4, which leads to a similar diagnosis sometimes referred to as Van Maldergem syndrome 2. Test results can’t predict every feature or severity, but they help guide care and family planning.
Is Van maldergem syndrome 1 genetic?
Genetics is central in Van Maldergem syndrome 1, which stems from inherited changes in DCHS1. Most cases follow autosomal recessive inheritance, so both parents are typically carriers. Genetic testing confirms the diagnosis and enables carrier and prenatal options.
Pharmacogenetics—how genetics influence drug effects
There’s no medicine that targets the root cause of Van Maldergem syndrome 1, so care focuses on symptoms and support. The genetic changes behind the condition don’t usually alter the body’s main drug‑processing systems, but treatment often involves medicines—such as anti‑seizure drugs, pain relievers, or medicines for muscle tone—where inherited differences in how quickly the liver breaks down a drug can affect safety and benefit. For example, some people break down certain anti‑seizure or pain medicines faster or slower, which can raise the risk of side effects or make a standard dose less effective. Alongside medical history and other medications, genetic testing can sometimes identify how your body responds to a drug and guide dosing or choice. Doctors also adjust treatments for features linked to Van Maldergem syndrome 1—such as breathing or feeding difficulties, airway differences, or kidney concerns—because these can change what’s safe during sedation, surgery, or long‑term therapy. Ask your care team about medications for Van Maldergem syndrome 1 and whether pharmacogenetic testing or extra monitoring could help tailor care over time.
Interactions with other conditions
Living with Van maldergem syndrome 1 often means juggling related health issues that can affect each other in everyday life—think frequent ear infections alongside hearing loss, or sleep apnea making daytime learning and behavior harder. Some people with Van maldergem syndrome 1 also have changes in how brain cells migrated before birth (called periventricular nodular heterotopia), which can raise the chance of seizures; when epilepsy is present too, seizure medicines, sleep quality, and learning supports all need to be coordinated. Certain diseases may “overlap,” meaning features of this syndrome can look similar to other rare craniofacial or developmental conditions, so clear diagnosis helps avoid mixed treatment plans. Recurrent airway infections, feeding difficulties, and reflux can interact, where congestion or poor weight gain may flare when another problem is active. Hearing loss together with speech and motor delays can compound communication and mobility challenges, so therapies often work best when planned together rather than one at a time. If early symptoms of Van maldergem syndrome 1 include feeding or breathing issues, addressing them promptly can reduce knock-on effects on growth, sleep, and development.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described children with unusually flexible joints, distinctive facial features, and later learning and movement differences, long before anyone knew a name for it. Families sometimes remembered an older relative with similar traits, noticing patterns that seemed to repeat across generations, though not in every child.
From early case reports in the late 20th and early 21st centuries, clinicians began to recognize a recurring cluster of findings that set some children apart from better-known conditions. As more specialists compared notes, they saw shared features—wide‑set eyes, small ears, joint laxity, and differences in bone growth—that hinted at a single underlying cause. Initially understood only through symptoms, later studies brought careful imaging and developmental follow‑up, which made the pattern clearer and more consistent.
With advances in genetics, researchers linked this pattern to changes in a gene involved in how cells shape and signal to each other during development. This discovery helped unite scattered case descriptions under one diagnosis: Van Maldergem syndrome 1. Naming the condition did more than label it—it allowed teams around the world to pool experience, compare outcomes, and refine supportive care. In recent decades, knowledge has built on a long tradition of observation, turning isolated stories into a shared understanding.
As numbers grew, it became clear that Van Maldergem syndrome 1 varies widely. Some children have early feeding and muscle tone challenges; others show milder differences and reach milestones later but steadily. This variability, once a source of confusion, is now recognized as part of the condition’s natural range. It also explains why some early reports were hard to group together and why families sometimes went years without clear answers.
Genetic testing transformed the timeline from suspicion to diagnosis. What once depended on a specialist’s eye and many clinic visits can now be confirmed by analyzing a blood or saliva sample. This shift has allowed earlier identification, more tailored therapies, and better-informed family planning. It also helped distinguish Van Maldergem syndrome 1 from related conditions that look similar in infancy but follow different paths over time.
Today’s history of Van Maldergem syndrome 1 is still being written. Registries, family networks, and international collaborations continue to add detail about early symptoms of Van Maldergem syndrome 1, day‑to‑day needs, and long‑term health. Awareness of past misunderstandings can guide families and clinicians toward timely support, realistic expectations, and care plans that match each child’s strengths and challenges.